PSM-78870-91043 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-21
Dose 1 — Pfizer-BioNTech
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-08-31
Registered in v-safe
2021-08-31
Dose 3 — Pfizer-BioNTech
2021-09-29
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-10-05
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-10-12
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2021-11-30
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-03-01
Survey response — 6 months, dose 3
MedDRA: Nasopharyngitis — Feeling: Good

Free text: Several colds brought home from my toddler

MedDRA releases: 2024-11 · check-in free text available
2022-09-02
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-21	Pfizer-BioNTech	No
2	2021-01-12	Pfizer-BioNTech	No
3	2021-08-31	Pfizer-BioNTech	No

Free text

Release 11 — 6 months, dose 3

2022-03-01

Symptoms: Several colds brought home from my toddler

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasopharyngitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release